enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Sputnik V COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine

    An article published by the journal Nature on 6 July 2021 cited data released by the United Arab Emirates on some 81,000 individuals who had received Sputnik V, according to which the vaccine demonstrated an efficacy of 97.8% in preventing symptomatic COVID-19, and 100% efficacy in preventing severe complications.

  3. Sputnik Light - Wikipedia

    en.wikipedia.org/wiki/Sputnik_Light

    A vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the 95% confidence interval. [6] As of September 2021, no study on Sputnik Light reported confidence intervals, so it is not possible to know the accuracy of the estimates. Effectiveness is generally expected to slowly decrease over time. [7]

  4. COVID-19 vaccination in Russia - Wikipedia

    en.wikipedia.org/wiki/COVID-19_vaccination_in_Russia

    The head of the Russian Direct Investment Fund (RDIF) stated that 20 countries had requested in total 1 billion doses of the vaccine, nicknamed Sputnik V. [11] On August 20 registration was called "conditional" with final registration depends on results of Phase 3 trial, [12] such registration is limited and allowed by Decree 441 for medicines ...

  5. At vaccine time, don’t forget about shingles. Here’s who ...

    www.aol.com/news/vaccine-time-don-t-forget...

    For premium support please call: 800-290-4726 more ways to reach us

  6. The scientist behind Russia's 'Sputnik' vaccine - AOL

    www.aol.com/news/scientist-behind-russias...

    Alexander Gintsburg is the head of the Gamaleya Institute -- the organization that produced Russia's Sputnik V vaccine. Its development is coming at a rapid pace -- amid what he calls "wartime ...

  7. File:SputnikVEfficacy001.svg - Wikipedia

    en.wikipedia.org/wiki/File:SputnikVEfficacy001.svg

    English: Sputnik V efficacy for different conditions. Data from: Logunov D. Y. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

  8. GSK's RSV, Shingles vaccines show on-par immune ... - AOL

    www.aol.com/news/gsks-rsv-shingles-vaccines-show...

    The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study. The co-administration ...

  9. Zoster vaccine - Wikipedia

    en.wikipedia.org/wiki/Zoster_vaccine

    A zoster vaccine is a vaccine that reduces the incidence of herpes zoster (shingles), a disease caused by reactivation of the varicella zoster virus, which is also responsible for chickenpox. [8] Shingles provokes a painful rash with blisters, and can be followed by chronic pain ( postherpetic neuralgia ), as well as other complications.